The apex court was hearing the DMA's petition which also sought...
Category:
Eco/Invest/Demography
Latest
Modi 3.0: Govt drops privatisation plans
Among other plans, the government intends to introduce succession...
India’s population to peak in early 2060s to 1.7 billion before declining: UN
"The population of India, which is expected to remain the world's...
IRDA likely to ask life insurers to launch Index Linked Insurance Products
There is a need exists to have ILIP which would not only give more options and alternatives to the policyholders to choose from, but also could help the insurers to manage their asset liability management risks in a better way, said the panel
General insurers allowed `use and file’ way for launching Personal Accident ,Overseas Travel cover
In respect of the personal accident, domestic and overseas travel products “use and file” is allowed only if the coverage offered both under base covers and add-on covers or riders is contingent upon an accident and/or travel as relevant.
Musk’s Tesla electrifies bitcoin with $1.5 billion bet, car payments pledge
Analysts said it could help accelerate a move for bitcoin move towards the mainstream that has seen both Paypal, also co-founded by Musk, and huge global money manager BlackRock move to accept the currency.
Central banks remain skeptical of digital currencies, but analysts say the more real world uses appear for bitcoin, the more attractive it will prove as a long-term store of value.
Factbox: What caused the deadly avalanche in the Indian Himalayas?
Vikram Gupta, a scientist at the federal government’s Wadia Institute of Himalayan Geology, said investigators were studying whether a rise in temperatures led to the avalanche, but results would not be known until later in the week.
Health insurance to see higher double-digits growth in medium term: Report
“While Covid-19-like scenarios would be rare events, it would increase the premium pricing for the entire populace, with extra care needed for the treatment of infectious diseases,” the report said.
India proved wrong all those who raised apprehensions: PM on govt’s handling of Covid-19 pandemic
Modi said there were predictions like crores would be infected and lakhs would die.
He said India emerged as a hub of pharmacy for the world during the pandemic, and added that the country is implementing the world’s largest vaccination programme.
Experimental drug can speed up Covid-19 recovery, says new study
“This treatment has large therapeutic potential, especially at this moment as we see aggressive variants of the virus spreading around the globe which are less sensitive to both vaccines and treatment with antibodies,” said study co-author Jordan Feld from the Toronto Centre for Liver Disease in Canada.
Govt’s disinvestment policy not akin to ‘selling family silver’: FM
Union Finance Minister Nirmala Sitharaman reiterated that the government would have bare minimum presence in the strategic sectors where it is very important for the government to stay.
The Finance Minister who presented her third Budget on February 1 noted that the strategic sectors will not remain totally under the government’s domain and private players too will be allowed in the sectors.
Govt allocates ₹16000 crore for Pradhan Mantri Fasal Bima Yojana for 2021-22
The number of farmers’ crop insurance claims that were rejected by insurance companies under the Pradhan Mantri Fasal Bima Yojana (PMFBY) multiplied 9 times in just two years.
According to data provided by Agriculture Minister Narendra Singh Tomar in response to a question in the Rajya Sabha on Friday, in 2017-18, the number of rejected claims was 92,869.
In the next year, 2018-19, the figure more than doubled to 204742. By 2019-20, it was 928870 , a whopping 900 percent increase,” the reply said.
Astrazeneca gets nod to use ant-diabetes drug for kidney disease in India
“Despite currently available therapies, a significant unmet need for effective management of CKD continues to exist globally. With the approval of dapagliflozin for CKD in India, an already effective type-2 diabetes and select heart failure treatment, can now be used by nephrologists in the management of CKD,” AstraZeneca India Vice President – Medical Affairs and Regulatory Anil Kukreja said.